- Home
- TXO vs MNMD Comparison
TXO vs MNMD Comparison
Compare TXO & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXO
- MNMD
- Stock Information
- Founded
- TXO 2012
- MNMD 2019
- Country
- TXO United States
- MNMD United States
- Employees
- TXO N/A
- MNMD N/A
- Industry
- TXO Oil & Gas Production
- MNMD Pharmaceuticals and Biotechnology
- Sector
- TXO Energy
- MNMD Health Care
- Exchange
- TXO Nasdaq
- MNMD Nasdaq
- Market Cap
- TXO 810.9M
- MNMD 672.1M
- IPO Year
- TXO 2023
- MNMD N/A
- Fundamental
- Price
- TXO $19.83
- MNMD $7.63
- Analyst Decision
- TXO
- MNMD Strong Buy
- Analyst Count
- TXO 0
- MNMD 10
- Target Price
- TXO N/A
- MNMD $28.11
- AVG Volume (30 Days)
- TXO 99.9K
- MNMD 3.1M
- Earning Date
- TXO 03-04-2025
- MNMD 03-06-2025
- Dividend Yield
- TXO 12.01%
- MNMD N/A
- EPS Growth
- TXO N/A
- MNMD N/A
- EPS
- TXO N/A
- MNMD N/A
- Revenue
- TXO $285,451,000.00
- MNMD N/A
- Revenue This Year
- TXO N/A
- MNMD N/A
- Revenue Next Year
- TXO $32.37
- MNMD N/A
- P/E Ratio
- TXO N/A
- MNMD N/A
- Revenue Growth
- TXO N/A
- MNMD N/A
- 52 Week Low
- TXO $15.22
- MNMD $4.66
- 52 Week High
- TXO $23.56
- MNMD $12.22
- Technical
- Relative Strength Index (RSI)
- TXO 65.96
- MNMD 47.18
- Support Level
- TXO $19.38
- MNMD $7.81
- Resistance Level
- TXO $20.70
- MNMD $10.44
- Average True Range (ATR)
- TXO 0.61
- MNMD 1.01
- MACD
- TXO 0.04
- MNMD -0.06
- Stochastic Oscillator
- TXO 64.49
- MNMD 29.07
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization and exploitation of oil, natural gas, and natural gas liquid reserves in North America.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.